Researchers will conduct a clinical trial this fall to test the effects of Strattera and behavioral therapy for children with attention-deficit/hyperactivity disorder and autism spectrum disorders. Doctors in Pennsylvania and Ohio will recruit 144 children ranging in ages from 5 to 13 for the 10-week trial. One group will receive Strattera, a non-stimulant medication used to treat ADHD. Parents of children in another group will receive training on how to use behavioral interventions as another...
Read moreIf you take medication for ADHD symptoms, chances are you use a stimulant medication such as Adderall, Ritalin or Concerta. These types of... Read more »
Strattera was the first non-stimulant medication approved to treat symptoms of ADHD.For more information:Strattera Read more »
Reporter Joanna Silberner looks at the case of a boy with autism who suffered adverse reactions to a medication because his body was not able to... Read more »
Source: First DataBank
Generic Name: ATOMOXETINE - ORAL Pronounced: (at-oh-MOX-eh-teen) Warning Studies have shown that a small number of people... Read more »
Source: HealthCentral Encyclopedia
Autistic disorder (known also as infantile autism or childhood autism) almost always develops before the age of three and is characterized by... Read more »
This is a study to assess the effects of Strattera on symptoms of attention-deficit hyperactivity disorder (ADHD) in children and teens who have both... Read more »
The U.S. Food and Drug Administration (FDA) has granted approval for Atomoxetine HCl--a generic version of the ADHD medication Strattera. The FDA... Read more »